DE602004025509D1 - Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon - Google Patents

Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon

Info

Publication number
DE602004025509D1
DE602004025509D1 DE602004025509T DE602004025509T DE602004025509D1 DE 602004025509 D1 DE602004025509 D1 DE 602004025509D1 DE 602004025509 T DE602004025509 T DE 602004025509T DE 602004025509 T DE602004025509 T DE 602004025509T DE 602004025509 D1 DE602004025509 D1 DE 602004025509D1
Authority
DE
Germany
Prior art keywords
virus
interleukin
latent phase
vii
homologue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004025509T
Other languages
English (en)
Inventor
Barry Slobedman
Allison Denise Abendroth
Christina Anne Jenkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003906613A external-priority patent/AU2003906613A0/en
Application filed by University of Sydney filed Critical University of Sydney
Publication of DE602004025509D1 publication Critical patent/DE602004025509D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE602004025509T 2003-11-28 2004-11-26 Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon Active DE602004025509D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003906613A AU2003906613A0 (en) 2003-11-28 Interleukin-10 Homologue and Uses Thereof
PCT/AU2004/001675 WO2005052159A1 (en) 2003-11-28 2004-11-26 Latent phase viral interleukin-10-(vii-10) and uses thereof

Publications (1)

Publication Number Publication Date
DE602004025509D1 true DE602004025509D1 (de) 2010-03-25

Family

ID=34624267

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004025509T Active DE602004025509D1 (de) 2003-11-28 2004-11-26 Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon

Country Status (6)

Country Link
US (2) US8133700B2 (de)
EP (1) EP1702068B1 (de)
AT (1) ATE457353T1 (de)
AU (1) AU2004293499B2 (de)
DE (1) DE602004025509D1 (de)
WO (1) WO2005052159A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
PT2379115T (pt) 2008-12-17 2018-01-03 Merck Sharp & Dohme Produção de mono- e di-peg-il-10; e utilizações
MX2015014438A (es) 2013-04-18 2016-05-18 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
EP3434277A1 (de) 2013-06-17 2019-01-30 Armo Biosciences, Inc. Verfahren zur beurteilung der proteinidentität und -stabilität
CA2920679A1 (en) 2013-08-30 2015-03-05 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
AU2014344807A1 (en) * 2013-10-29 2016-05-19 The University Of Sydney CMV immuno-stimulatory composition
AU2014346537A1 (en) 2013-11-11 2016-05-19 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN106573072A (zh) 2014-06-02 2017-04-19 阿尔莫生物科技股份有限公司 降低血清胆固醇的方法
CA2963989A1 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
MX2017004983A (es) 2014-10-22 2017-11-13 Armo Biosciences Inc Metodos para usar interleucina 10 para tratar enfermedades y trastornos.
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
WO2016168741A2 (en) * 2015-04-16 2016-10-20 Spencer Juliet V Detection of human cytomegalovirus
CN107847583A (zh) 2015-05-28 2018-03-27 阿尔莫生物科技股份有限公司 用于治疗癌症的聚乙二醇化白细胞介素‑10
MX2018002298A (es) 2015-08-25 2018-07-06 Armo Biosciences Inc Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016153A1 (en) * 1999-09-02 2001-03-08 University Of Medicine And Dentistry Of New Jersey Cytomegalovirus-encoded il-10 homolog
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
EP1379637A4 (de) 2001-03-27 2005-04-06 Dendreon Corp Transmembran-serinprotease 9 codierende nukleinsäuremoleküle, die codierten polypeptide sowie darauf beruhende verfahren
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
WO2005012545A2 (en) * 2003-07-25 2005-02-10 The Regents Of The University Of California Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors

Also Published As

Publication number Publication date
US20090214463A1 (en) 2009-08-27
US8133700B2 (en) 2012-03-13
US20120134957A1 (en) 2012-05-31
WO2005052159A8 (en) 2005-08-18
EP1702068B1 (de) 2010-02-10
AU2004293499A1 (en) 2005-06-09
ATE457353T1 (de) 2010-02-15
EP1702068A1 (de) 2006-09-20
AU2004293499B2 (en) 2009-11-26
WO2005052159A1 (en) 2005-06-09
EP1702068A4 (de) 2007-07-11

Similar Documents

Publication Publication Date Title
DE602004025509D1 (de) Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
EA200400023A1 (ru) Ингибиторы вич-протеазы, содержащие их композиции, их фармацевтическое использование и материалы для их синтеза
NO20052956L (no) Defensinprotiner
ATE256667T1 (de) Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen
NO20091788L (no) Antibakterielle og antivirale peptider fra Actinomadura namibiensis
WO2007030708A3 (en) Antimicrobial adzymes and uses thereof
EA200501711A1 (ru) Семейство секретируемых белков
JP2008522632A5 (de)
DE69834194D1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
ATE397624T1 (de) Cystine-knot fold protein
ATE549352T1 (de) Verwendung sekretierter proteinprodukte zur prävention und behandlung von erkrankungen der bauchspeicheldrüse und/oder adipositas und/oder des metabolischen syndroms
NO20054900L (no) Sekrert proteinfamilie
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE328080T1 (de) Proteine und für diese kodierende dna
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
WO2004014936A3 (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications.
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
HUP0302416A2 (hu) Tisztított hepatitis-C vírusmembrán-proteinek diagnosztikai és terápiás célú alkalmazása
DE69824001D1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
DE60124523D1 (de) Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
De Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses
WO2003095482A3 (fr) Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.
BR9608837A (pt) "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition